Key Documents

View All Documentation

327484

Platinum

Name: Platinum
Brand: ALDRICH

shot, ≤3 mm, ≥99.9% trace metals basis

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):

CAS Number:

7440-06-4

Molecular Weight:

195.08

NACRES:

NA.23

PubChem Substance ID:

24859665

UNSPSC Code:

12141734

EC Number:

231-116-1

MDL number:

MFCD00011179

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

Quality Level

100

assay

≥99.9% trace metals basis

form

shot

composition

reaction suitability

core: platinum

resistivity

10.6 μΩ-cm, 20°C

particle size

≤3 mm

bp

3827 °C (lit.)

mp

1772 °C (lit.)

density

21.45 g/cm³ (lit.)

SMILES string

[Pt]

InChI

1S/Pt

InChI key

BASFCYQUMIYNBI-UHFFFAOYSA-N

Description

Application

Platinum shot may be used in the preparation of (La_xCe_1-x)_1.33Pt₄Ga₁₀(0≤ x ≤1) single crystals, a potential non Fermi-liquid (NFL).

Storage Class

13 - Non Combustible Solids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Synthesis, structure, and magnetic behavior of (LaxCe 1- x) 1.33 Pt 4 Ga 10 (0? x? 1).

Macaluso, et al.

J. Alloy Compounds, 600, 193-198 (2014)

Interstitial lung disease associated with gefitinib in Japanese patients with EGFR-mutated non-small-cell lung cancer: combined analysis of two Phase III trials (NEJ 002 and WJTOG 3405).

Hiroaki Akamatsu et al.

Japanese journal of clinical oncology, 43(6), 664-668 (2013-04-16)

Interstitial lung disease associated with gefitinib is a critical adverse reaction. When geftinib was administered to EGFR-unknown patients, the interstitial lung disease incidence rate was approximately 3-4% in Japan, and usually occurs during the first 4 weeks of treatment. However

Antibacterial performance of nanoscaled visible-light responsive platinum-containing titania photocatalyst in vitro and in vivo.

Yao-Hsuan Tseng et al.

Biochimica et biophysica acta, 1830(6), 3787-3795 (2013-04-02)

Traditional antibacterial photocatalysts are primarily induced by ultraviolet light to elicit antibacterial reactive oxygen species. New generation visible-light responsive photocatalysts were discovered, offering greater opportunity to use photocatalysts as disinfectants in our living environment. Recently, we found that visible-light responsive

View All Related Papers